Wall Street analysts predict that Itron, Inc. (NASDAQ:ITRI) will post earnings of $0.66 per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Itron’s earnings. The highest EPS estimate is $0.80 and the lowest is $0.58. Itron reported earnings of $0.70 per share in the same quarter last year, which would indicate a negative year over year growth rate of 5.7%. The firm is scheduled to report its next quarterly earnings results on Monday, May 4th.
On average, analysts expect that Itron will report full-year earnings of $3.53 per share for the current fiscal year, with EPS estimates ranging from $3.25 to $3.68. For the next financial year, analysts forecast that the company will post earnings of $4.62 per share, with EPS estimates ranging from $4.01 to $5.00. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research analysts that cover Itron.
Itron (NASDAQ:ITRI) last issued its quarterly earnings data on Monday, February 24th. The scientific and technical instruments company reported $0.72 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.54 by $0.18. Itron had a net margin of 1.96% and a return on equity of 17.47%. The firm had revenue of $628.38 million for the quarter, compared to the consensus estimate of $587.14 million. During the same period last year, the firm posted $0.88 EPS. Itron’s quarterly revenue was up 7.0% compared to the same quarter last year.
ITRI has been the topic of several analyst reports. ValuEngine raised shares of Itron from a “sell” rating to a “hold” rating in a research report on Tuesday. JMP Securities reissued an “outperform” rating and issued a $95.00 target price on shares of Itron in a research report on Tuesday, February 25th. Stephens dropped their target price on shares of Itron from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 26th. Argus downgraded shares of Itron from a “buy” rating to a “hold” rating in a research report on Thursday, March 19th. Finally, BidaskClub downgraded shares of Itron from a “hold” rating to a “sell” rating in a research report on Tuesday, March 10th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the company. Itron currently has a consensus rating of “Buy” and a consensus price target of $83.13.
In related news, SVP Sharelynn Faye Moore sold 663 shares of the company’s stock in a transaction on Monday, February 24th. The shares were sold at an average price of $80.15, for a total transaction of $53,139.45. Following the completion of the transaction, the senior vice president now directly owns 5,576 shares in the company, valued at approximately $446,916.40. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Thomas Deitrich sold 8,252 shares of the company’s stock in a transaction on Monday, February 24th. The shares were sold at an average price of $80.15, for a total transaction of $661,397.80. Following the transaction, the chief executive officer now owns 139,098 shares of the company’s stock, valued at $11,148,704.70. The disclosure for this sale can be found here. Insiders sold 12,472 shares of company stock valued at $999,631 over the last 90 days. 2.35% of the stock is owned by corporate insiders.
Large investors have recently added to or reduced their stakes in the stock. Tower Research Capital LLC TRC raised its stake in shares of Itron by 1,196.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 350 shares of the scientific and technical instruments company’s stock valued at $29,000 after buying an additional 323 shares in the last quarter. Nisa Investment Advisors LLC raised its stake in shares of Itron by 76.2% in the 4th quarter. Nisa Investment Advisors LLC now owns 370 shares of the scientific and technical instruments company’s stock valued at $31,000 after buying an additional 160 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. acquired a new position in shares of Itron in the 4th quarter valued at $39,000. Penserra Capital Management LLC acquired a new position in shares of Itron in the 4th quarter valued at $41,000. Finally, Robecosam AG raised its stake in shares of Itron by 2.7% in the 4th quarter. Robecosam AG now owns 231,500 shares of the scientific and technical instruments company’s stock valued at $84,000 after buying an additional 6,000 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.
Shares of NASDAQ ITRI traded up $5.19 during midday trading on Thursday, reaching $62.83. The company’s stock had a trading volume of 38,419 shares, compared to its average volume of 434,676. The company has a current ratio of 1.49, a quick ratio of 1.15 and a debt-to-equity ratio of 1.25. The company has a 50 day moving average price of $72.67 and a 200 day moving average price of $77.86. Itron has a one year low of $40.48 and a one year high of $88.32. The company has a market cap of $2.53 billion, a price-to-earnings ratio of 51.80, a price-to-earnings-growth ratio of 0.62 and a beta of 1.10.
Itron Company Profile
Itron, Inc, a technology and service company, provides end-to-end solutions that measures, manages, and analyzes energy and water use worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing.
Further Reading: What is a resistance level?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.